Literature DB >> 17979828

Pigment epithelium-derived factor (PEDF) prevents advanced glycation end products (AGEs)-elicited endothelial nitric oxide synthase (eNOS) reduction through its anti-oxidative properties.

Sho-ichi Yamagishi1, Seiji Ueda, Takanori Matsui, Kazuo Nakamura, Tsutomu Imaizumi, Masayoshi Takeuchi, Seiya Okuda.   

Abstract

PEDF is an effective inhibitor of angiogenesis in the eye with neuronal differentiating activity. Here, we show that PEDF prevents the AGEs-elicited eNOS reduction through its anti-oxidative properties. Our present study suggests that PEDF may also play a protective role against atherosclerosis.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17979828     DOI： 10.2174/092986607781483705

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN： 0929-8665            Impact factor:   1.890


  11 in total

Review 1.  Advanced glycation end products and diabetic retinopathy.

Authors:  Yashodhara Sharma; Sandeep Saxena; Arvind Mishra; Anita Saxena; Shankar Madhav Natu
Journal:  J Ocul Biol Dis Infor       Date:  2013-04-19

Review 2.  Endothelial dysfunction: the role of sterol regulatory element-binding protein-induced NOD-like receptor family pyrin domain-containing protein 3 inflammasome in atherosclerosis.

Authors:  Zhen Chen; Marcy Martin; Zhao Li; John Y-J Shyy
Journal:  Curr Opin Lipidol       Date:  2014-10       Impact factor: 4.776

3.  A proteomic focus on the alterations occurring at the human atherosclerotic coronary intima.

Authors:  Fernando de la Cuesta; Gloria Alvarez-Llamas; Aroa S Maroto; Alicia Donado; Irene Zubiri; Maria Posada; Luis R Padial; Angel G Pinto; Maria G Barderas; Fernando Vivanco
Journal:  Mol Cell Proteomics       Date:  2011-01-19       Impact factor: 5.911

4.  Vitamin D Deficiency May Not Be an Independent Risk Factor for Peripheral Arterial Disease in Middle-Aged and Elderly Patients with Type 2 Diabetes in China.

Authors:  Yan Wang; Tongbao Feng; Hongxing Zhou; Kefeng Lu; Yang Bai; Ping Zhang
Journal:  Dis Markers       Date:  2020-11-25       Impact factor: 3.434

5.  Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy.

Authors:  Masayoshi Takeuchi; Jun-Ichi Takino; Sho-Ichi Yamagishi
Journal:  J Ophthalmol       Date:  2010-06-22       Impact factor: 1.909

6.  Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.

Authors:  Sho-Ichi Yamagishi; Nobutaka Nakamura; Mika Suematsu; Kuniyoshi Kaseda; Takanori Matsui
Journal:  Mol Med       Date:  2015-10-27       Impact factor: 6.354

Review 7.  Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications.

Authors:  Sho-ichi Yamagishi; Kei Fukami; Takanori Matsui
Journal:  Cardiovasc Diabetol       Date:  2015-01-13       Impact factor: 9.951

8.  Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis.

Authors:  Sho-Ichi Yamagishi; Takanori Matsui
Journal:  Ann Vasc Dis       Date:  2018-09-25

9.  PEDF in diabetic retinopathy: a protective effect of oxidative stress.

Authors:  Xiao-feng Zhu; Hai-dong Zou
Journal:  J Biomed Biotechnol       Date:  2012-04-10

10.  Apolipoprotein E Gene Polymorphism, Glycated Hemoglobin, and Peripheral Arterial Disease Risk in Chinese Type 2 Diabetic Patients.

Authors:  Yujing Hu; Tinghuan Ling; Min Yu; Yang Bai; Tongbao Feng; Ping Zhang; Yan Wang
Journal:  Dis Markers       Date:  2020-03-07       Impact factor: 3.434
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.